Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Indiana mass spectrometry firm, Perfinity Biosciences, raises $2.3 million

Stealthy mass spectrometry company Perfinity Biosciences has raised $2.3 million in equity, just over a month after it pulled in nearly the same amount, according to regulatory filings.

Perfinity was created as by West Lafayette, Indiana-based Quadraspec Inc., which makes DVD-like discs that can hold up to 272 biological samples and be analyzed by reading machines. Quadraspec has raised more than $20 million in outside capital, and its shareholders will remain Perfinity’s owners, the Indiana Business Journal reported.

Perfinity has filed a patent for a new method of preparing biological samples for mass spectrometry, an analytical technique to identify and quantify the chemical structure of molecules. The patent is based on work done by Fred Regnier, a Purdue University faculty member and co-founder of Quadraspec.

Neither Perfinity nor Quadraspec appear to have websites.

In Perfinity’s most recently filed regulatory document, the company said it raised $2.33 million in equity from 26 investors. In the regulatory document filed in May, the company said it raised $2.33 million in equity from 156 investors.

The company recently hired Steven Plump, a former Eli Lilly & Co. executive, to be its interim president. Plump wasn’t available for comment.

Disclosure: This author has no position in the company.